Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of ID-085 in Renal Impairment
NCT03913000Phase 1Completed
- Sponsor
- Idorsia
- Start
- Apr 2019
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of ID-085 (4 arms), sponsored by Idorsia. Primary endpoints: Area under the plasma concentration-time curve from time zero to time t of the last measured concentration above the limit of quantification, Area under the plasma concentration-time curve from zero to infinity and 4 more. Started Apr 2019; status: completed.
02
Drugs
ID-085
Beyond the preview
Go deeper on NCT03913000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03913000.